Sun Pharma Advanced Research Company Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
SPARC has submitted a routine compliance certificate to the stock exchanges for the quarter ended March 31, 2026. The certificate was issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime). It confirms that all share certificates received for dematerialization during the January–March 2026 quarter were duly processed, accepted or rejected, and the underlying securities were listed on the stock exchanges. The certificates have been mutilated and cancelled, and the depositories' names have been substituted as registered owners in the company's member register within the required timelines. This is a standard regulatory submission under SEBI's Depository Regulations and does not relate to any business or financial event.
This is a routine compliance filing with no impact on the company's operations, financials, or stock price. It simply confirms that share dematerialization activities for the quarter were carried out properly.